JP2002525313A5 - - Google Patents

Download PDF

Info

Publication number
JP2002525313A5
JP2002525313A5 JP2000571896A JP2000571896A JP2002525313A5 JP 2002525313 A5 JP2002525313 A5 JP 2002525313A5 JP 2000571896 A JP2000571896 A JP 2000571896A JP 2000571896 A JP2000571896 A JP 2000571896A JP 2002525313 A5 JP2002525313 A5 JP 2002525313A5
Authority
JP
Japan
Prior art keywords
weight
enteric
composition
water
flake material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000571896A
Other languages
English (en)
Japanese (ja)
Other versions
JP4662634B2 (ja
JP2002525313A (ja
Filing date
Publication date
Priority claimed from US09/162,282 external-priority patent/US6139875A/en
Application filed filed Critical
Publication of JP2002525313A publication Critical patent/JP2002525313A/ja
Publication of JP2002525313A5 publication Critical patent/JP2002525313A5/ja
Application granted granted Critical
Publication of JP4662634B2 publication Critical patent/JP4662634B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000571896A 1998-09-29 1999-09-13 胃透過性の低い水性腸溶性被覆組成物 Expired - Fee Related JP4662634B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/162,282 1998-09-29
US09/162,282 US6139875A (en) 1998-09-29 1998-09-29 Aqueous enteric coating composition and low gastric permeability enteric coating
PCT/US1999/021072 WO2000018376A1 (en) 1998-09-29 1999-09-13 Aqueous enteric coating composition with low gastric permeability

Publications (3)

Publication Number Publication Date
JP2002525313A JP2002525313A (ja) 2002-08-13
JP2002525313A5 true JP2002525313A5 (enExample) 2006-11-24
JP4662634B2 JP4662634B2 (ja) 2011-03-30

Family

ID=22584979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000571896A Expired - Fee Related JP4662634B2 (ja) 1998-09-29 1999-09-13 胃透過性の低い水性腸溶性被覆組成物

Country Status (5)

Country Link
US (1) US6139875A (enExample)
EP (1) EP1117385B1 (enExample)
JP (1) JP4662634B2 (enExample)
DE (1) DE69928555T2 (enExample)
WO (1) WO2000018376A1 (enExample)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US7883721B2 (en) * 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
KR100461566B1 (ko) * 2001-11-15 2004-12-14 삼성정밀화학 주식회사 수계 분산 히드록시프로필메틸 셀룰로오스 프탈레이트나노입자의 제조방법
SE0103839D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Pharmaceutical formulation & product
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
KR100511086B1 (ko) * 2003-09-17 2005-08-30 삼성정밀화학 주식회사 장용성의 수계 분산 히드록시프로필 메틸셀룰로오스프탈레이트 나노입자의 제조방법
KR20050080626A (ko) * 2004-02-10 2005-08-17 삼성정밀화학 주식회사 수계분산 히드록시프로필 메틸셀룰로오스 프탈레이트나노입자 조성물의 제조방법
TW200539903A (en) 2004-03-12 2005-12-16 Smithkline Beecham Plc Pharmaceutical formulations
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
US20060018957A1 (en) * 2004-07-26 2006-01-26 Lerner E I Pharmaceutical dosage forms including rasagiline
AU2006275476A1 (en) * 2005-08-01 2007-02-08 Alpharma Inc. Alcohol resistant pharmaceutical formulations
US20070122477A1 (en) * 2005-10-12 2007-05-31 Cytochroma, Inc. Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency
US20070092559A1 (en) * 2005-10-24 2007-04-26 Jinghua Yuan Liquid dosage forms having enteric properties of delayed and then sustained release
PT3095447T (pt) 2006-02-03 2022-01-24 Opko Renal Llc Tratamento da insuficiência e deficiência de vitamina d com 25-hidroxivitamina d2 e 25-hidroxivitamina d3
DK2037936T3 (da) 2006-06-21 2014-09-22 Opko Renal Llc Fremgangsmåde til behandling og forebyggelse af sekundær hyperparathyroidisme
US8968799B2 (en) * 2006-09-01 2015-03-03 Rise-N-Shine L.L.C. Time delayed release mechanism for energizing composition and method of use
KR101691876B1 (ko) 2007-04-25 2017-01-02 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
EP2148685A4 (en) * 2007-04-25 2010-07-28 Cytochroma Inc METHODS AND COMPOUNDS FOR THERAPY BASED ON VITAMIN D
CA2683628C (en) * 2007-04-25 2018-03-06 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
ES3047207T3 (en) 2007-04-25 2025-12-03 Opko Renal Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
ES2593356T3 (es) 2008-04-02 2016-12-07 Opko Ireland Global Holdings, Ltd. Métodos, composiciones, usos y kits útiles para la deficiencia de la vitamina D y trastornos relacionados
CA2984935C (en) 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US20120189670A1 (en) * 2009-09-14 2012-07-26 Kirkpatrick D Lynn Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
US20110217426A1 (en) * 2010-03-04 2011-09-08 Perry Stephen C Enteric coating composition
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
JP6357292B2 (ja) 2012-12-14 2018-07-11 フューシス セラピューティクス、インク． Ｃｎｋｓｒ１を阻害するための方法及び組成物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
WO2015153841A1 (en) 2014-04-04 2015-10-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
CA2983260C (en) 2015-04-20 2024-01-23 Phusis Therapeutics, Inc. Sulfonamide compounds, compositions and methods for inhibiting cnksr1
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US20160331689A1 (en) 2015-05-12 2016-11-17 SE Tylose USA, Inc. Aqueous enteric coating composition
JP6855469B2 (ja) 2015-10-16 2021-04-07 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 消化器標的療法のための処方物を調製するための工程
KR20180093903A (ko) 2015-11-03 2018-08-22 더 브리검 앤드 우먼즈 하스피털, 인크. 음식 알레르기의 치료 및/또는 예방을 위한 치료용 미생물총
KR20180123100A (ko) 2016-03-28 2018-11-14 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3473245A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
EP3473244A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
CN111566128B (zh) 2017-11-10 2022-06-21 营养与生物科学美国4公司 独特形态的多糖
WO2019118674A1 (en) 2017-12-14 2019-06-20 E. I. Du Pont De Nemours And Company Alpha-1,3-glucan graft copolymers
EP3723775A4 (en) 2017-12-15 2022-04-13 Solarea Bio, Inc. MICROBIAL COMPOSITIONS AND METHODS OF TREATING TYPE 2 DIABETES, OBESITY AND METABOLIC SYNDROME
FR3083545A1 (fr) 2018-07-04 2020-01-10 Institut National De La Recherche Agronomique Utilisation d'une souche de roseburia intestinalis pour la prevention et le traitement de l'inflammation de l'intestin
WO2020051379A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
CN113574074B (zh) 2018-10-25 2023-03-21 营养与生物科学美国第四公司 α-1,3-葡聚糖接枝共聚物
CN113543658A (zh) 2018-11-05 2021-10-22 奇迹生物公司 包含鞣花单宁的微生物组合物及使用方法
WO2020257722A2 (en) 2019-06-19 2020-12-24 Solarea Bio, Inc. Microbial compositions and methods for producing upgraded probiotic assemblages
EP4055063A1 (en) 2019-11-06 2022-09-14 Nutrition & Biosciences USA 4, Inc. Highly crystalline alpha-1,3-glucan
US11733011B2 (en) * 2020-11-24 2023-08-22 Raytheon Company Steering system with power take-off from actuators
EP4436407A1 (en) 2021-11-22 2024-10-02 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities
WO2025064621A1 (en) 2023-09-19 2025-03-27 Flagship Pioneering Innovations Vi, Llc Compositions and methods for treating colorectal cancer
WO2025064645A1 (en) 2023-09-19 2025-03-27 Flagship Pioneering Innovations Vi, Llc Compositions and methods for treating inflammatory bowel disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150111A (en) * 1974-05-28 1979-04-17 Allister Warren Enteric coated magnesium chloride
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
JPH07552B2 (ja) * 1987-11-06 1995-01-11 田辺製薬株式会社 持効性製剤
US5026559A (en) * 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
US5104922A (en) * 1990-10-22 1992-04-14 E. I. Du Pont De Nemours And Company Stable aqueous aluminum flake dispersion
JP2925346B2 (ja) * 1991-03-18 1999-07-28 田辺製薬株式会社 腸溶性製剤およびその製法
WO1995016451A1 (fr) * 1992-06-22 1995-06-22 Franck Arno Gouchet Comprimes a liberation controlee de 4-asa
US5330759A (en) * 1992-08-26 1994-07-19 Sterling Winthrop Inc. Enteric coated soft capsules and method of preparation thereof
US5733575A (en) * 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
JPH08109126A (ja) * 1994-10-07 1996-04-30 Amano Pharmaceut Co Ltd 耐衝撃性腸溶性顆粒剤およびこれを含有する錠剤
US5612397A (en) * 1994-12-19 1997-03-18 Rohm And Haas Company Composition having wet state clarity
JPH08245423A (ja) * 1995-03-06 1996-09-24 Shionogi & Co Ltd 水系腸溶性コーティング液
JPH08333240A (ja) * 1995-06-02 1996-12-17 Shin Etsu Chem Co Ltd 粉末またはペレット状ワックスを用いる無溶媒腸溶性コーティング剤で被覆した腸溶性製剤
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
US5756008A (en) * 1996-08-14 1998-05-26 E. I. Du Pont De Nemours And Company Water cleanable silver composition

Similar Documents

Publication Publication Date Title
JP4662634B2 (ja) 胃透過性の低い水性腸溶性被覆組成物
JP5430815B2 (ja) 低溶解性活性成分の延長された放出のための、複数のマイクロカプセルの形体である経口医薬品製剤
Dashevsky et al. Physicochemical and release properties of pellets coated with Kollicoat® SR 30 D, a new aqueous polyvinyl acetate dispersion for extended release
Siepmann et al. Polymer blends for controlled release coatings
US6699506B1 (en) Pharmaceutical composition with extended release of Milnacipran
KR101973235B1 (ko) 에탄올의 영향에 대해 지속 방출 특성 및 내성을 갖는 제약 또는 기능식품 조성물
Sato et al. Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method
JP2007510677A (ja) 調節性の物質の放出に影響を及ぼすマトリックスを有する多層の剤形
NZ517554A (en) Oral pharmaceutical forms of administration of tramadol with a delayed action
US20130309311A1 (en) Pellet formulation for the treatment of the intestinal tract
WO1991015194A1 (en) Taste masking of ibuprofen by fluid bed coating
Junyaprasert et al. Release profile comparison and stability of diltiazem–resin microcapsules in sustained release suspensions
Jain et al. Development and characterization of eudragit RS 100 loaded microsponges and its colonic delivery using natural polysaccharides
JPS56127322A (en) Enteric coating material composition for solid drug
HU203968B (en) Aqueous dispersions for coating drug forms
US20080254115A1 (en) Micropellet Containing Pellets and Method of Preparing Such Pellets
EP0559645A1 (en) Composition for solid pharmaceutical preparations containing active vitamins d 3? and process for preparation thereof
WO2001010467A1 (fr) Preparations solides contenant de la poudre de chitosane et procede de production associe
JPS5942325A (ja) コ−テイング用組成物及びコ−テイング製剤
Lamprecht et al. Observations in simultaneous microencapsulation of 5-fluorouracil and leucovorin for combined pH-dependent release
Basavaraj et al. HOLLOW MICROSPHERES OF DICLOFENAC SODIUM-A GASTRORETENTIVE CONTROLLED DELIVERY SYSTEM.
Zhai et al. Gastroretentive extended-release floating granules prepared using a novel fluidized hot melt granulation (FHMG) technique
Alhnan et al. Inhibiting the gastric burst release of drugs from enteric microparticles: the influence of drug molecular mass and solubility
Bhardwaj et al. Formulation and in-vitro evaluation of floating microballoons of indomethacin
Osterwald Properties of film-formers and their use in aqueous systems